Avalyn Pharma's CEO Leads Workshop on Clinical Strategy at
Seattle, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of targeted therapies...
Stay updated with breaking news from Hanson Wade. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Seattle, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of targeted therapies...
Pressroom: Hier finden Sie die gesammelten Presseaussendungen von Acousia Therapeutics GmbH
NEW YORK, May 17, 2023) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that its Chief Medical
Fourteen antibody-drug conjugates (ADCs) have been approved globally for cancer indications so far. This article shares considerations for...
We may no longer be living in the fast-and-furious days of Emergency Use Authorization, nor are we all working strictly on mRNA vaccines. But after...